Publikācijas » Search Results » 2009 » Konferences

 2017  2016  2015  2014  2013  2012  2011  2010  2009  2008  2007  2006  2005  2004  2003  2002  2001  2000  1999  1998  1997  1996  1995  1994  1993  1992  1991  1990  1989  1988  1987  1986  1985  1984  1983  1982  1981  1980  1979  1978  1977  1976  1975  1974  1973  1972  1971  1970  1969  1968  1967  1966  1965  1964  1962
Rezultātu skaits lapā  
41Soualmi S.; Ignatovich L.; Lukevics E.; Jouikov V. Anodic reactivity of all-five and all-six-membered 1-substituted silatranes and germatranes. Programme, Abstracts, and List of Participants, 5th European Silicon Days; 20th-22nd September: Vienna, Austria, 2009; 45.      

42Sokolovska J.; Kalviņš I.; Šaripova J.; Ļauberte L.; Sjakste N. Mildronāts pozitīvi ietekmē ogļhidrātu un tauku metabolismu žurku diabēta streptozotocīna modelī . Konferences programma, LU 67. zinātniskā konference. Dabaszinātnes. Medicīna; 6. febr.: Rīga, Latvija, 2009; 54.      

43Švalbe B.; Zvejniece L.; Muceniece R.; Dambrova M. Kodola faktora-kappaB inhibitora pretsāpju un prettiekaisuma effects. Konferences programma, LU 67. zinātniskā konference. Dabaszinātnes. Medicīna; 6. febr.: Rīga, Latvija, 2009; 52.      

44Dambrova M.; Konrade I.; Jankevics A.; Skapare E.; Pugovics O.; Liepinsh E. The comparative metabolomics of the experimental rat and diabetic patients urinary composition. Abstract Volume in Journal of the European Association fot the Study of Diabetes (EASD) (Diabetologia, Vol.52, Suppl.1), 45th EASD Annual Meeting; 29 September - 2 October: Vienna, Austria, 2009; 145.      

45Dambrova M. Regulation of cellular energy metabolism by mildronate. Different pharmacological activity of optical isomers of CNS active drugs. Abstracts, The 2nd Korea International Women,s Invention Exposition-Forum; May 1-4, 2009; 159.      

46Makrecka M.; Kūka J.; Škapare E. Metabolā sindroma un otrā tipa diabēta eksperimentālo modeļu salīdzinājums. Tēzes, 58. Medicīnas nozares studentu zinātniskā konference; 1. aprīlis: Rīgas Stradiņa Universitāte, Latvija, 2009; 12.      

47Skorova A.; Veretennikova N.; Lukevics E. Prediction of biological activity for organic compounds using OREX expert system. Scientific Programme. Plenary Lecture, Major Talks, Short & Oral Communications. Abstracts a. Background of the Speakers, International Symposium on Advances in Synthetic and Medicinal Chemistry = ASMC; August 23-27: Kiev, Ukraine (www.asmc09.org), 2009; 190.      

48Skrivele B.; Pajuste K.; Kaldre D.; Plotniece A.; Ose V.; Sobolev A.; Danne R.; Cekavicus B.; Birjukovs P.; Erts D.; Duburs G. The influence of preparation conditions on nanoaggregates formed by self-assembling amphiphilic pyridinium derivatives. Abstracts, 23rd Conference of the European Colloid and Interface Society = ECIS 2009 (September 6-11), 3rd D43 Action Workshop (September 7-8); : P.D43.055. Antalya, Turkey, 2009.      

49Svalbe B.; Zvejniece L.; Muceniece R.; Dambrova M. Anti-inflammatory and antinociceptive effects of NF-kappaB inhibitor. Abstracts, 13th annual Symposium for Biology Students of Europe = SymBioSE2009. Biology: Expansion of Borders ; 30 July – 8 August: Kazan State University, Tatarstan Republic, Russia, 2009; 110.      

50Zvejniece L.; Dambrova M. Differential pharmacological activity of optical isomers of CNS drugs. Program. Book of Abstracts, 3rd International Symposium on Evidence Based Medicine on CNS, Sleep & Chronic Organic Disorders. 1st Latvian-Greek Medical Symposium; 3rd-6th July: Riga, Latvia, 2009; 38.      

Rezultātu skaits lapā